MingYue Lens Announces Significant Clinical Results for QingSongKong Pro: 68% Efficacy in Slowing Myopia Progression

ShanghaiNovember 28, 2022PR Newswire -- Recently, Mingyue Optical Lens and West China Hospital of Sichuan University held the 2022 Myopia Prevention and Control Clinical Application Seminar in Chengdu, and released the six-month clinical report on positive defocus lenses (Easy Control Pro). The report shows that: Easy Control Pro has a significant effect on myopia management. Compared with the three-month trial data, the latest results show that: Easy Control Pro's effectiveness in slowing the increase of myopia reaches 68%, and its effectiveness in delaying axial growth reaches 56%.

Rivaling Foreign Brands, Mingyue Optical Lens Takes Control EffortlesslyPro Myopia Management Effect is Obvious

At the beginning of this year, Mingyue Optical Lens Co., Ltd. and Professor Liu Longqian's team from West China Hospital of Sichuan University initiated the clinical follow-up trial of "Qingsong Control Pro." At the conference, Associate Professor Yang Bi, Ph.D. in Optometry and Vision Science from the Department of Optometry and Vision Science at West China Hospital of Sichuan University, along with Bian Siyu, the first participant in the "Qingsong Control" project at the hospital, provided a detailed introduction of the research background, methods, and follow-up results of the six-month clinical study.

Compared with the clinical data from the previous six months, the latest three months show a significant improvement: The effectiveness rate of Mingyue Optical Lens (Easy Control Pro) in slowing myopia progression reached 68%, reducing axial length growth by 56%, and curbing the increase in spherical equivalent by 60%. This indicates that the myopia control effect of Easy Control Pro becomes more pronounced over time. "These results highlight the potential of Mingyue Easy Control lenses in the future of myopia management," said Professor Yang Bi from Huaxi Hospital, expressing strong approval.

Defocus Patent Technology Designed for Chinese Children

"From a professional perspective, clinical trials are a very important means to verify the effectiveness of a product," said Liu Longqian, Director of the Department of Optometry and Ophthalmology at West China Clinical Medical College/West China Hospital, Sichuan University. The six-month clinical results of QingSong Control Pro further demonstrate the actual effectiveness of the product, which also benefits from the product's superiority.

"Easy Control Pro comprehensively considered the effect of degree control, wearing compliance and comfort at the beginning of the design," said Zhu Haifeng, director of the Research and Development Center of Mingyue Optical Lens.

Mingyue Easy Control Pro lens features 1,295 "Starry Sky" positive diopter micro-lenses, which project images in front of the retina in peripheral areas to create pre-retinal defocus. This helps suppress axial elongation and effectively slows down the progression of myopia. Additionally, the "shell-shaped" asymmetrical visual zone of the Easy Control Pro enhances wearing comfort, allowing children to adapt quickly and encouraging long-term use. Furthermore, unlike PC material lenses commonly available on the market, the Easy Control series uses resin material that is lighter, offers better optical performance, and provides increased safety.

The Most Comprehensive Product Line Debuts+ New KV featuring spokesperson Liu Haoran debuts

At the meeting, Mingyue Optical Lens released for the first time the new Relax Control KV featuring their spokesperson Liu Haoran. Meanwhile, two new products of Relax Control Pro were also launched: D71TF and D71TFL, along with eight medical versions. Up to now, the refractive index of Relax Control Pro ranges from 1.60 to 1.71, making it a more comprehensive product line of myopia management lenses for teenagers in China, meeting the different glasses fitting needs of various children.

Since its establishment, Mingyue Optical Lens has adhered to independent research and development as well as technological innovation. Recently, Mingyue Optical Lens has successively partnered with China Aerospace, the Changchun Institute of Optics, Fine Mechanics and Physics of the Chinese Academy of Sciences, and China Eye Valley. In the future, Mingyue Optical Lens will leverage the advanced clinical and technological capabilities of these research institutions to further enhance the development of myopia management products and contribute to myopia prevention and control for children in China.